TNNI3, ALA171THR

 
National Institutes of Health

Related topics

Related topics

1 relation
CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1 (disorder)

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
TNNI3K is a novel mediator of myofilament function and phosphorylates cardiac troponin I
The phosphorylation of cardiac troponin I (cTnI) plays an important role in the contractile dysfunction associated with heart… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
2013
2013
Inhibition of the cardiomyocyte-specific kinase TNNI3K limits oxidative stress, injury, and adverse remodeling in the ischemic heart.
Percutaneous coronary intervention is first-line therapy for acute coronary syndromes (ACS) but can promote cardiomyocyte death… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
Deletion Of P 53 In Endothelial Cells Prevents Cardiac Fibrosis And Heart Failure Induced By Pressure Overload In Mice Via Enhanced Angiogenesis
Dual stem cell transplantation of c-kit positive cardiac progenitor cells (CPCs) and mesen-chymal stem cells (MSCs) after… (More)
Is this relevant?
2008
2008
Overexpression of TNNI3K, a cardiac-specific MAP kinase, promotes P19CL6-derived cardiac myogenesis and prevents myocardial infarction-induced injury.
TNNI3K is a new cardiac-specific MAP kinase whose gene is localized to 1p31.1 and that belongs to a tyrosine kinase-like branch… (More)
Is this relevant?